Liminatus Pharma Inc. Cla...

NASDAQ: LIMN · Real-Time Price · USD
3.79
-0.18 (-4.53%)
At close: Aug 19, 2025, 3:59 PM
3.83
1.06%
After-hours: Aug 19, 2025, 07:52 PM EDT

Liminatus Pharma Class A Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-405 -4.82M -2.71M -2.53M
Interest Income
n/a 10K n/a 16.84K
Pretax Income
-405 -4.98M -2.93M 4.37M
Net Income
-405 -4.98M -2.93M 4.37M
Selling & General & Admin
2.91M 1.06M 856K 2.53M
Research & Development
n/a 3.76M 1.85M n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
2.91M 4.82M 2.71M 2.53M
Interest Expense
n/a 175K 219K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
2.91M 4.82M 2.71M 2.53M
Income Tax Expense
18.84K 33.99K n/a n/a
Shares Outstanding (Basic)
100.00 26.71M 26.71M 34.5M
Shares Outstanding (Diluted)
100.00 26.71M 26.71M 34.5M
EPS (Basic)
-4.05 -0.19 -0.11 0.13
EPS (Diluted)
-4.05 -0.19 -0.11 0.13
EBITDA
-405 -4.81M -2.71M 4.37M
EBIT
n/a -4.81M -2.71M 4.37M
Depreciation & Amortization
n/a n/a n/a n/a